[go: up one dir, main page]

MX2015017880A - Método para el tratamiento y/o prevención contra encefalopatia traumática cronica grado i. - Google Patents

Método para el tratamiento y/o prevención contra encefalopatia traumática cronica grado i.

Info

Publication number
MX2015017880A
MX2015017880A MX2015017880A MX2015017880A MX2015017880A MX 2015017880 A MX2015017880 A MX 2015017880A MX 2015017880 A MX2015017880 A MX 2015017880A MX 2015017880 A MX2015017880 A MX 2015017880A MX 2015017880 A MX2015017880 A MX 2015017880A
Authority
MX
Mexico
Prior art keywords
preventing
treating chronic
chronic traumatic
traumatic encephalopathy
encephalopathy
Prior art date
Application number
MX2015017880A
Other languages
English (en)
Other versions
MX370176B (es
Inventor
Vink Robert
Original Assignee
Eustralis Pharmaceuticals Ltd (Trading As Pressura Neuro)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013902455A external-priority patent/AU2013902455A0/en
Application filed by Eustralis Pharmaceuticals Ltd (Trading As Pressura Neuro) filed Critical Eustralis Pharmaceuticals Ltd (Trading As Pressura Neuro)
Publication of MX2015017880A publication Critical patent/MX2015017880A/es
Publication of MX370176B publication Critical patent/MX370176B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un método para prevenir y/o tratar encefalopatía traumática crónica.
MX2015017880A 2013-07-02 2014-07-02 Método para el tratamiento y/o prevención contra encefalopatia traumática cronica grado i. MX370176B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013902455A AU2013902455A0 (en) 2013-07-02 Method for preventing and/or treating chronic traumatic encephalopathy - i
PCT/AU2014/050107 WO2015000032A1 (en) 2013-07-02 2014-07-02 Method for preventing and/or treating chronic traumatic encephalopathy-i

Publications (2)

Publication Number Publication Date
MX2015017880A true MX2015017880A (es) 2016-09-22
MX370176B MX370176B (es) 2019-12-04

Family

ID=52142941

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015017880A MX370176B (es) 2013-07-02 2014-07-02 Método para el tratamiento y/o prevención contra encefalopatia traumática cronica grado i.

Country Status (14)

Country Link
US (3) US10729677B2 (es)
EP (1) EP3016642B1 (es)
JP (1) JP2016523866A (es)
KR (1) KR20160030506A (es)
CN (1) CN105451727B (es)
AU (2) AU2014286925A1 (es)
BR (1) BR112015032161A2 (es)
CA (1) CA2914515C (es)
IL (1) IL242899B (es)
MX (1) MX370176B (es)
RU (1) RU2016103099A (es)
SG (1) SG11201509932XA (es)
WO (1) WO2015000032A1 (es)
ZA (1) ZA201508871B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729677B2 (en) 2013-07-02 2020-08-04 Eustralis Pharmaceutical Limited (Trading As Pressura Neuro) Method for preventing and/or treating chronic traumatic encephalopathy-I
RU2709614C1 (ru) * 2018-03-06 2019-12-19 Арман Женисович ЛУРЬЕ Способ лечения энцефалопатии
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ514600A0 (en) * 2000-01-18 2000-02-10 James Cook University Brain injury treatment
US20030083345A1 (en) 2001-07-10 2003-05-01 Torsten Hoffmann Method of treatment and/or prevention of brain, spinal or nerve injury
WO2008067610A1 (en) 2006-12-08 2008-06-12 Adelaide Research & Innovation Pty Ltd Method for reducing inflammatory responses and inflammation
CA2700477A1 (en) * 2007-07-19 2009-01-22 Adelaide Research & Innovation Pty Ltd Method for reducing intracranial pressure
US8877768B2 (en) * 2009-09-18 2014-11-04 Chase Pharmaceuticals Corporation Method and composition for treating alzheimer-type dementia
CA2831054C (en) 2013-01-09 2016-08-30 Sapna Life Sciences Corp. Formulations, and methods for their use in treatment of neuropathology and neurodegeneration as a result of traumatic injury
US8992951B2 (en) * 2013-01-09 2015-03-31 Sapna Life Sciences Corporation Formulations, procedures, methods and combinations thereof for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma
US10501494B2 (en) 2013-04-26 2019-12-10 Creative Bio-Peptides Uses of peptides to treat brain injury and disease
US10729677B2 (en) * 2013-07-02 2020-08-04 Eustralis Pharmaceutical Limited (Trading As Pressura Neuro) Method for preventing and/or treating chronic traumatic encephalopathy-I
KR102275705B1 (ko) 2014-07-11 2021-07-09 삼성전자주식회사 웨이퍼 대 웨이퍼 접합 구조

Also Published As

Publication number Publication date
EP3016642A1 (en) 2016-05-11
US12419861B2 (en) 2025-09-23
ZA201508871B (en) 2017-04-26
SG11201509932XA (en) 2016-01-28
CN105451727A (zh) 2016-03-30
US10729677B2 (en) 2020-08-04
CA2914515C (en) 2018-12-11
US11426384B2 (en) 2022-08-30
RU2016103099A (ru) 2017-08-07
US20160143881A1 (en) 2016-05-26
HK1220642A1 (en) 2017-05-12
BR112015032161A2 (pt) 2017-07-25
AU2019257493A1 (en) 2019-11-21
CN105451727B (zh) 2019-04-23
US20210100773A1 (en) 2021-04-08
AU2019257493B2 (en) 2021-04-01
US20220218663A1 (en) 2022-07-14
IL242899B (en) 2018-12-31
RU2016103099A3 (es) 2018-05-25
MX370176B (es) 2019-12-04
EP3016642B1 (en) 2019-03-13
WO2015000032A1 (en) 2015-01-08
CA2914515A1 (en) 2015-01-08
AU2014286925A1 (en) 2015-12-17
KR20160030506A (ko) 2016-03-18
EP3016642A4 (en) 2017-03-08
JP2016523866A (ja) 2016-08-12

Similar Documents

Publication Publication Date Title
CL2016001063A1 (es) Locus optimos de la soja.
EP3540243C0 (de) Spreizanker
EP2991666A4 (en) SIALYLATED GLYCOPROTEINS
HUE051746T2 (hu) Eljárások MASP-2-függõ komplement aktiválással kapcsolatos állapotok kezelésére
IL259479B (en) Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor
IL241461B (en) Methods for treating osteogenesis imperfecta
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
PT2964616T (pt) Inibidores da neprilisina
BR302014000415S1 (pt) Configuração aplicada em lâmpada
DK2984184T3 (da) Anvendelse af dnq eller dnq-87 i kombination med en parp1-inhibitor til behandlingen af cancer
PT3016682T (pt) Métodos para tratamento do cancro
AR097668A1 (es) Colorante-polímero
BR112019004481A2 (pt) aptâmeros específicos de pd-1
HRP20181876T1 (hr) Inhibitor za retinokoroidalne poremećaje
AU2019257493A1 (en) Method for preventing and/or treating chronic traumatic encephalopathy-I
ZA201508872B (en) Method for preventing and/or treating chronic traumatic encephalopathy-ii
KR20180084962A (ko) 마스터 디스크 및 그 장착 방법과 분리 방법
ES2542377B1 (es) Luminaria para iluminacion de emergencia en tuneles
CY1119212T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
BR112016004054A2 (pt) composições e métodos para o tratamento de condições nasais
EP3390241A4 (en) Holographic laminate
BR112016005246A2 (pt) Solenoide
BR302014002186S1 (pt) Configuração aplicada em dispositivo luminoso
ES1079081Y (es) Lengüeta para dulzaina o similar
ES1079879Y (es) Pieza para bisuteria y joyeria.

Legal Events

Date Code Title Description
FG Grant or registration